S-Space

Browse

Subject

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2011-03	The regulation of FOXP3 expression by the treatment of TGF-β and the modification of DNA methylation in lung cancer cell lines Um, S.-W.; Lee, S.H.; Kim, H.; Kwon, O.J.; Kim, H.; Kang, J.S.; Lee, W.J. Tuberculosis and Respiratory Diseases, Vol.70 No.3, pp.206-217	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	view file DOI
2019-09	Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer Ock, Chan-Young; Yoo, Shin-Hye; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong Wan; Chung, Doo Hyun; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.34 No.5, pp.1116-1124	view file DOI